Loading organizations...
Loading organizations...
Develops radiotherapeutics for cancer treatment and imaging.
Ratio Therapeutics has raised $70.0M across 2 funding rounds.
Ratio Therapeutics has raised $70.0M in total across 2 funding rounds.
Ratio Therapeutics has raised $70.0M in total across 2 funding rounds.
Ratio Therapeutics's investors include Duquesne, Schusterman, Bristol Myers Squibb, Cornell University, Mey Boukenna , M.D., Ph.D., Duquesne Capital, Schusterman Family Investments.
Ratio Therapeutics has raised $70.0M across 2 funding rounds. Most recently, it raised $50.0M Series B in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 18, 2024 | $50.0M Series B | Duquesne, Schusterman | Bristol Myers Squibb, Cornell University, Mey Boukenna , M.D., Ph.D. |
| Feb 1, 2023 | $20.0M Series A | Duquesne Capital, Schusterman Family Investments |